在血液性恶性瘤中TPL的作用
Tingyun Xu1, Yiwei Zhu2, Shuaishuai Ge3
1Suzhou Key Laboratory of Medical Biotechnology, Suzhou Vocational Health College, Suzhou, People's Republic of China.
Hematology (Amsterdam, Netherlands)
|July 5, 2023
概括
来自Tripterygium wilfordii的化合物Triptolide (TPL) 通过诱导亡并增强血液瘤的化疗,显示出强大的抗癌作用. 研究重点是TPL衍生物和低剂量组合,以提高疗效和降低毒性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
- 传统中国医药 传统中国医药
背景情况:
- 特里普托利德 (TPL) 是一种来自Tripterygium wilfordii的二类植物,具有显著的抗瘤,免疫抑制和抗炎作用.
- 通过诱导亡,抑制增殖,促进自和铁亡,TPL证明了对血液瘤的有效性.
- 它还提高了传统化疗和向治疗的有效性,涉及NF-κB,BCR-ABL和Caspase等途径.
研究的目的:
- 审查最近在血液瘤中TPL分子机制的进展.
- 讨论TPL结构类似物和低剂量策略的开发和应用.
- 探索TPL在治疗血液恶性瘤中的临床应用和未来方向.
主要方法:
- 在过去二十年中,对Triptolide (TPL) 和其衍生物在血液瘤中的研究进行文献综述.
- 分子机制的分析,包括亡诱导,细胞增殖抑制,自和铁亡.
- 对TPL类似物和组合疗法的临床前和临床数据的检查.
主要成果:
- TPL有效地诱导细胞亡,并抑制血液瘤细胞的增殖.
- 自和铁死由TPL促进,有助于其抗癌作用.
- 低剂量TPL (IC20) 和TPL衍生品正在研究以克服溶解性和毒性问题,有前临床结果很有希望.
结论:
- ptolide (TPL) 是血液瘤的有希望的治疗剂,具有多样化的分子机制.
- 结构修改和优化剂量策略对于开发更安全,更有效的基于TPL的疗法至关重要.
- 对TPL衍生物和组合治疗的进一步临床研究对于血液性恶性瘤是有必要的.
相关概念视频
01:28Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
01:22Bone Marrow Sampling and Transplants
363
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
363
01:21Hematopoiesis
5.4K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.4K
01:21Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
01:21Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K